Esperion Therapeutics (0IIM.LSE) Q4 2023 Earnings

27FebConfirmed
Q4 2023
-0.5
-0.49
-0.49
-0.48

Details

Expected EPS
-0.481692
Actual EPS
-0.5
Surprise EPS
-0.02
Surprise Percent
+3.8%

Description

Esperion Therapeutics (0IIM.LSE) has reported earnings of -0.5 per share for Q4 2023.

0 Comments

Share your thoughts